Vα24-invariant NKT cells from patients with allergic asthma express CCR9 at high frequency and induce Th2 bias of CD3+ T cells upon CD226 engagement

Journal of Immunology

Volumn 175, Issue 8, 2005, Pages 4914-4926

  Sen, Yang ^a   Yongyi, Bi ^b   Yuling, He ^b   Luokun, Xie ^b   Li, He ^b   Jie, Xiong ^b,c   Tao, Deng ^d   Gang, Zhou ^b   Junyan, Liu ^b   Chunsong, Hu ^a   Zhang, Xuejun ^a   Youxin, Jin ^c   Feili, Gong ^e   Boquan, Jin ^f   Jinquan, Tan ^a,b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^d WUHAN UNIVERSITY   (China)

^e HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^f FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD226 ANTIGEN; CHEMOKINE; CHEMOKINE CCL25; CHEMOKINE RECEPTOR CCR9; CYTOKINE; MONOCLONAL ANTIBODY; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ARTICLE; BRONCHUS MUCOSA; CELL ACTIVATION; CELL CONTACT; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 26844537217     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.8.4914     Document Type: Article

References (58)

1. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 26: 877-900.
2. Bendelac, A., M. N. Rivera, S. H. Park, and J. H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15: 535-562.
3. Godfrey, D. I., H. R. MacDonald, M. Kronenberg, M. J. Smyth, and L. Van Kaer. 2004. NKT cells: what's in a name? Nat. Rev. Immunol. 4: 231-237.
4. Hong, S., M. T. Wilson, I. Serizawa, L. Wu, N. Singh, O. V. Naidenko, T. Miura, T. Haba, D. C. Scherer, J. Wei, et al. 2001. The natural killer T cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7: 1052-1056.
5. Sharif, S., G. A. Arreaza, P. Zucker, Q. S. Mi, J. Sondhi, O. V. Naidenko, M. Kronenberg, Y. Koezuka, T. L. Delovitch, J. M. Gombert, et al. 2001. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat. Med. 7: 1057-1062.
6. Schofield, L., M. J. McConville, D. Hansen, A. S. Campbell, B. Fraser-Reid, M. J. Grusby, and S. D. Tachado. 1999. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 283: 225-229.
7. Kronenberg, M., and L. Gapin. 2002. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2: 557-568.
8. Akbari, O., P. Stock, E. Meyer, M. Kronenberg, S. Sidobre, T. Nakayama, M. Taniguchi, M. J. Grusby, R. H. DeKruyff, and D. T. Umetsu. 2003. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9: 582-588.
9. Lisbonne, M., S. Diem, A. de Castro Keller, J. Lefort, L. M. Araujo, P. Hachem, J. M. Fourneau, S. Sidobre, M. Kronenberg, M. Taniguchi, et al. 2003. Cutting edge: invariant Vα14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 171: 1637-1641.
10. Kim, C. H., E. C. Butcher, and B. Johnston. 2002. Distinct subsets of human Vα24-invariant NKT cells: cytokine responses and chemokine receptor expression. Trends Immunol. 23: 516-519.
11. Hayakawa, Y., K. Takeda, H. Yagita, L. Van Kaer, I. Saiki, and K. Okumura. 2001. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J. Immunol. 166: 6012-6018.
12. Kadowaki, N., S. Antonenko, S. Ho, M. C. Rissoan, V. Soumelis, S. A. Porcelli, L. L. Lanier, and Y. J. Liu. 2001. Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J. Exp. Med. 193: 1221-1226.
13. Miyamoto, K., S. Miyake, and T. Yamamura. 2001. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing Th2-bias of natural killer T cells. Nature 413: 531-534.
14. + NKT cell subsets with distinct cytokine-producing capacity. Blood 100: 11-16.
15. Lee, P.T. K. Benlagha, L. Teyton, and A. Bendelac. 2002. Distinct functional lineages of human Vα24 natural killer T cells. J. Exp. Med. 195: 637-641.
16. Gumperz, J. E., S. Miyake, T. Yamamura, and M. B. Brenner. 2002. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195: 625-636.
17. Mora, J. R., M. R. Bono, N. Manjunath, W. Weninger, L. L. Cavanagh, M. Rosemblatt, and U. H. von Andrian. 2003. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424: 88-93.
18. Thomas, S. Y., R. Hou, J. E. Boyson, T. K. Means, C. Hess, D. P. Olson, J. L. Strominger, M. B. Brenner, J. E. Gumperz, S. B. Wilson, and A. D. Luster. 2003. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J. Immunol. 171: 2571-2580.
19. Shibuya, A., D. Campbell, C. Hannum, H. Yssel, K. Franz Bacon, T. McClanahan, T. Kitamura, J. Nicholl, G. R. Sutherland, L. L. Lanier, and J. H. Phillips. 1998. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 4: 573-581.
20. Burns, G. F., T. Triglia, J. A. Werkmeister, C. G. Begley, and A. W. Boyd. 1985. TLiSA, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursors. J. Exp. Med. 161: 1063-1078.
21. Bottino, C., R. Castriconi, D. Pende, P. Rivera, M. Nanni, B. Carnemolla, C. Cantoni, J. Grassi, S. Marcenaro, N. Reymond, et al. 2003. Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J. Exp. Med. 198: 557-567.
22. Sherrington, P. D., J. L. Scott, B. Jin, D. Simmons, D. J. Dorahy, J. Lloyd, J. H. Brien, R. H. Aebersold, J. Adamson, M. Zuzel, and G. F. Burns. 1997. TIiSA (PTA1) activation antigen implicated in T cell differentiation and platelet activation is a member of the regulation of expression. J. Biol. Chem. 272: 21735-21744.
23. Kojima, H., H. Kanada, S. Shimizu, E. Kasama, K. Shibuya, H. Nakauchi, T. Nagasawa, and A. Shibuya. 2003. CD226 mediates platelet and megakaryocytic cell adhesion to vascular endothelial cells. J. Biol. Chem. 278: 36748-36753.
24. Shibuya, K., L. L. Lanier, J. H. Phillips, H. D. Ochs, K. Shimizu, E. Nakayama, H. Nakauchi, and A. Shibuya. 1999. Physical and functional association of LFA-1 with DNAM-1 adhesion molecule. Immunity 11: 615-623.
25. Shibuya, K., J. Shirakawa, T. Kameyama, S. Honda, S. Tahara-Hanaoka, A. Miyamoto, M. Onodera, T. Sumida, H. Nakauchi, H. Miyoshi, and A. Shibuya. 2003. CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. J. Exp. Med. 198: 1829-1839.
26. Reymond, N., A. M. Imbert, E. Devilard, S. Fabre, C. Chabannon, L. Xerri, C. Farnarier, C. Cantoni, C. Bottino, A. Moretta, P. Dubreuil, and M. Lopez. 2004. DNAM-1 and PVR regulate monocyte migration through endothelial junctions. J. Exp. Med. 199: 1331-1341.
27. Castriconi, R., A. Dondero, M. V. Corrias, E. Lanino, D. Pende, L. Moretta, C. Bottino, and A. Moretta. 2004. Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-polio-virus receptor interaction. Cancer Res. 64: 9180-9184.
28. Tao, D., L. Shangwu, W. Qun, L. Yan, J. Wei, L. Junyan, G. Feili, J. Boquan, and T. Jinquan. 2005. CD226 expression deficiency causes high sensitivity to apoptosis in NK T cells from patients with systemic lupus erythematosus. J. Immunol. 174: 1281-1290.
29. Jinquan, T., S. Quan, H. H. Jacobi, C. M. Reimert, A. Millner, J. B. Hansen, C. Thygesen, L. P. Ryder, H. O. Madsen, H. J. Malling, and L. K. Poulsen. 1999. Expression of the nuclear factors of activated T cells in eosinophils: regulation by IL-4 and IL-5. J. Immunol. 163: 21-24.
30. + hematopoietic progenitors from human cord blood induced by granulocyte- macrophage colony-stimulating factor: chemotaxis and adhesion induced by its ligands, interferon γ-inducible protein 10 and monokine induced by interferon γ. Blood 96: 1230-1238.
31. Chalmers, I. M., G. Janossy, M. Contreras, and C. Navarrete. 1998. Intracellular cytokine profile of cord and adult blood lymphocytes. Blood 92: 11-18.
32. Heid, C. A., J. Stevens, K. J. Livak, and P. M. William. 1996. Real-time quantitative PCR. Genome Res. 6: 986-994.
33. Kruse, N., M. Pette, K. Toyka, and P. Rieckmann. 1997. Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood. J. Immunol. Methods 210: 195-203.
34. Jinquan, T., H. H. Jacobi, C. Jing, A. Millner, L. Anting, E. Sten, L. Hviid, L. P. Ryder, C. Glue, P. S. Skov, et al. 2003. CC chemokine receptor 3 expression induced by IL-2 and IL-4 functioning as a death receptor for B cells. J. Immunol. 171: 1722-1731.
35. Sica, A., A. Saccani, A. Borsatti, C. A. Power, T. N. Wells, W. Luini, N. Polentarutti, S. Sozzani, and A. Mantovani. 1997. Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J. Exp. Med. 185: 969-974.
36. Massari, P., Y. Ho, and L. M. Wetzler. 2000. Neisseria meningitidis porin PorB interacts with mitochondria and protects cells from apoptosis. Proc. Natl. Acad. Sci. USA 97: 9070-9075.
37. Jinquan, T., J. Frydenberg, N. Mukaida, J. Bonde, C. G. Larsen, K. Matsushima, and K. Thestrup-Pedersen. 1995. Recombinant human growth regulated oncogene-α induces T lymphocyte chemotaxis: a process regulated via interleukin-8 receptors by IFN-γ, TNF-α, IL-4, IL-10 and IL-13. J. Immunol. 155: 5359-5368.
38. + T lymphocyte migration. J. Immunol. 151: 4545-4551.
39. Margaret, A. H., and G. Philippe. 1996. Synthesis and characterization of strongly luminescence ZnS-capped CdSe nanocrystals. J. Phys. Chem. 100: 468-471.
40. Chan, W. C. W., and S. Nie. 1998. Quantum dot bioconjugates for ultrasensitive nonisotropic detection. Science 281: 2016-2018.
41. Sun, B., W. Xie, G. Yi, D. Chen, Y. Zhou, and J. Cheng. 2001. Microminiaturized immunoassays using quantum dots as fluorescent label by laser confocal scanning fluorescence detection. J. Immunol. Methods 249: 85-89.
42. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor α. J. Exp. Med. 179: 1109-1118.
43. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193: 1285-1294.
44. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192: 1213-1222.
45. Val promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. Nucleic Acids Res. 31: 700-707.
46. Maasho, K., A. Marusina, N. M. Reynolds, J. E. Coligan, and F. Borrego. 2004. Efficient gene transfer into the human natural killer cell line, NKL, using the Amaxa nucleofection system. J. Immunol. Methods 284: 133-140.
47. Youn, B. S., C. H. Kim, F. O. Smith, and H. E. Broxmeyer. 1999. TECK, an efficacious chemoattractant for human thymocytes, uses GPR-9-6/CCR9 as a specific receptor. Blood 94: 2533-2536.
48. Johnston, B., C. H. Kim, D. Soler, M. Emoto, and E. C. Butcher. 2003. Differential chemokine responses and homing patterns of murine TCRαβ NKT cell subsets. J. Immunol. 171: 2960-2969.
49. Stetson, D. B., M. Mohrs, R. L. Reinhardt, J. L. Baron, Z. E. Wang, L. Gapin, M. Kronenberg, and R. M. Locksley. 2003. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198: 1069-1076.
50. Campbell, J. J., C. E. Brightling, F. A. Symon, S. Qin, K. E. Murphy, M. Hodge, D. P. Andrew, L. Wu, E. C. Butcher, and A. J. Wardlaw. 2001. Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J. Immunol. 166: 2842-2848.
51. Godfrey, D. I., H. R. MacDonald, M. Kronenberg, M. J. Smyth, and L. Van Kaer. 2004. NKT cells: what's in a name? Nat. Rev. Immunol. 4: 231-237.
52. Matsuda, J. L., O. V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C. R. Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192: 741-754.
53. Prussin, C., and B. Foster. 1997. TCR V-α-24 and V-β-11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation. J. Immunol. 159: 5862-5870.
54. Godfrey, D. I., and M. Kronenberg. 2004. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114: 1379-1388.
55. + NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J. Immunol. 166: 6477-6482.
56. + gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J. Exp. Med. 200: 1511-1517.
57. Papadakis, K. A., C. Landers, J. Prehn, E. A. Kouroumalis, S. T. Moreno, J. C. Gutierrez-Ramos, M. R. Hodge, and S. R. Targan. 2003. CC chemokine receptor 9 expression defines a subset of peripheral blood lymphocytes with mucosal T cell phenotype and Th1 or T regulatory 1 cytokine profile. J. Immunol. 171: 159-165.
58. + NK T cells activated by α-galactosylceramide- pulsed monocyte-derived dendritic cells. J. Immunol. 168: 3140-3144.